(Q63817906)

English

Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

SDALS-001 (English)
0 references
Phase 2 Selection Trial of High Dosage Creatine and Two Dosages of Tamoxifen in Amyotrophic Lateral Sclerosis (ALS) (English)
0 references
March 2011
0 references
December 2012
0 references
60
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit